Reducing intratumour acute hypoxia through bevacizumab treatment, referring to the response of quiescent tumour cells and metastatic potential

British Journal of Radiology

Volumn 84, Issue 1008, 2011, Pages 1131-1138

  Masunaga, Shin Ichiro ^a   Liu, Y ^a   Tanaka, H ^b   Sakurai, Y ^b   Suzuki, M ^a   Kondo, N ^a   Maruhashi, A ^b   Ono, K ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; BROXURIDINE; NICOTINAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL ASSAY; CELL ISOLATION; CELL LABELING; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL EFFECTIVENESS; CLONOGENESIS; CONTROLLED STUDY; FEMALE; GAMMA IRRADIATION; HYPERTHERMIC THERAPY; HYPOXEMIA; IMMUNOFLUORESCENCE TEST; LUNG METASTASIS; MELANOMA; MELANOMA CELL; METASTASIS INHIBITION; MICRONUCLEUS TEST; MILD TEMPERATURE HYPERTHERMIA; MOUSE; NONHUMAN; OXYGENATION; RADIOSENSITIZATION; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR HYPOXIA;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; CELL HYPOXIA; COMBINED MODALITY THERAPY; FEMALE; GAMMA RAYS; HYPERTHERMIA, INDUCED; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; TUMOR CELLS, CULTURED;

EID: 82655186359     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/38457938     Document Type: Article

References (23)

1. Jain RK. Normalization of tumour vasculature: an emerging concept in antiangiogenic therapy. Science 2005;307:58-62. (Pubitemid 40093472)
2. Winkler F, Kozin SV, Tong RT, Chae S-S, Booth MF, Garkavtsev I, et al. Kineticas of vascular normalization by VEGFR2 blockade governs brain tumour response to radiation: role of oxygenation, angiopoietin-1, and matix metalloproteinases. Cancer Cell 2004;6:553-63. (Pubitemid 40017699)
3. Brown JM. Evidence of acutely hypoxic cells in mouse tumours and a possible mechanism of reoxygenation. Br J Radiol 1979;2:650-6. (Pubitemid 9239867)
4. Cairns BA, Kalliomaki T, Hill RP. Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumours. Cancer Res 2001;61:8903-8. (Pubitemid 34013907)
5. Rofstad EK, Galappathi K, Mathiesen B, Ruud E-BM. Fluctuating and diffusion-limited hypoxia in hypoxia-induced metastasis. Clin Cancer Res 2007;13:1971-8. (Pubitemid 46649862)
6. Masunaga S, Ono K, Suzuki M, Nishimura Y, Hiraoka M, Kinashi Y, et al. Alteration of the hypoxic fraction of quiescent cell populations by hyperthermia at mild temperatures. Int J Hyperthermia 1997;13:401-11. (Pubitemid 27363894)
7. Masunaga S, Matsumoto Y, Hirayama R, Kashino G, Tanaka H, Suzuki M, et al. Significance of hypoxia manipulation in solid tumours in the effect on lung metastases in radiotherapy, with reference to its effect on the sensitivity of intratumour quiescent cells. Clin Exp Metastasis 2009;26:693-700.
8. Masunaga S, Ono K. Significance of the response of quiescent cell populations within solid tumours in cancer therapy. J Radiat Res 2002;43:11-25. (Pubitemid 135693382)
9. Duan X, Zhang H, Liu B, Li XD, Gao QX, Wu ZH. Apoptosis of murine melanoma cells induced by heavy-ion radiation combined with Tp53 gene transfer. Int J Radiat Biol 2008;84:211-17. (Pubitemid 351323418)
10. Dings RPM, Loren M, Heun H, McNiel E, Griffioen AW, Mayo KH, et al. Scheduling of radiation with angiogenesis inhibitors anginex and avastin improves therapeutic outcome via vessel normalization. Clin Cancer Res 2007;13:3395-402. (Pubitemid 46944928)
11. Nishimura Y, Ono K, Hiraoka M, Masunaga S, Jo S, Shibamoto Y, et al. Treatment of murine SCC VII tumours with localized hyperthermia and temperature-sensitive liposomes containing cisplatin. Radiat Res 1990;122:161-7. (Pubitemid 20178989)
12. Ando K, Koike S, Ohira C, Chen YJ, Nojima K, Ando S, et al. (1999) Accelerated reoxygenation of a murine fibrosarcoma after carbon-ion radiation. Int J Radiat Biol 1999;75:505-12. (Pubitemid 29191549)
13. Vaupel P. Tumour microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol 2004;14:198-206. (Pubitemid 38903223)
14. De Jaeger K, Kavanagh M-C, Hill RP. Relationship of hypoxia to metastatic ability in rodent tumours. Br J Cancer 2001;84:1280-5. (Pubitemid 32511348)
15. Hall EJ. Time, dose, and fractionation in radiotherapy. In: Hall EJ and Giaccia AJ (eds). Radiobiology for the radiologist. 6th edn. Philadelphia, USA: Lippincott Williams &Wilkins, 2006:378-97.
16. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumours: a review. Cancer Res 1989;49:6449-65. (Pubitemid 20008770)
17. Chaplin DJ, Horsman MR, Trotter MJ. Effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumour. J Natl Cancer Inst 1990;82:672-6. (Pubitemid 20154274)
18. Song CW, Park H, Griffin RJ. Improvement of tumour oxygenation by mild hyperthermia. Radiat Res 2001;155:512-28.
19. Lu-Hesselmann J, Abend M, van Beuningen D. Comparison of endogeneous TP53 genomic status with clonogenicity and different models of cell death after X irradiation. Radiat Res 2004;161:39-47. (Pubitemid 38018722)
20. Presta LG, Chen H, O'Conner SJ, Chisholm V, Meng YG, Krummen L, et al. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumours and other disorders. Cancer Res 1997;57:4593-9. (Pubitemid 27441066)
21. Ma J, Waxman DJ. Combination of antiangiogenesis with chemotherapy for more effective cancer treatment. Mol Cancer Ther 2008;7:3670-84.
22. Jain RK, Tong RT, Munn LL. Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: Insights from a mathematical model. Cancer Res 2007;67:2729-35. (Pubitemid 46548961)
23. Moller MG, Lewis J M, Dessureault S, Zager JS. Toxicities associated with hyperthermic isolated limb perfusion and isolated limb infusion in the treatment of melanoma and sarcoma. Int J Hyperthermia 2008;24:275-89. (Pubitemid 351517160)